IFP Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.61M | Sell |
5,215
-76
| -1% | -$36.5K | 0.05% | 411 |
|
|
2026
Q1 | $2.6M | Sell |
5,291
-42
| -0.8% | -$22.8K | 0.05% | 379 |
|
|
2025
Q4 | $3.09M | Buy |
5,333
+1
| +0% | +$566 | 0.07% | 312 |
|
|
2025
Q3 | $2.59M | Sell |
5,332
-250
| -4% | -$116K | 0.07% | 319 |
|
|
2025
Q2 | $2.38M | Sell |
5,582
-331
| -6% | -$138K | 0.07% | 322 |
|
|
2025
Q1 | $2.94M | Sell |
5,913
-1,595
| -21% | -$864K | 0.09% | 260 |
|
|
2024
Q4 | $3.91M | Buy |
7,508
+1,178
| +19% | +$648K | 0.13% | 173 |
|
|
2024
Q3 | $3.92M | Buy |
6,330
+160
| +3% | +$94.7K | 0.14% | 154 |
|
|
2024
Q2 | $3.41M | Sell |
6,170
-32
| -0.5% | -$18.3K | 0.14% | 154 |
|
|
2024
Q1 | $3.61M | Sell |
6,202
-177
| -3% | -$99.3K | 0.16% | 140 |
|
|
2023
Q4 | $3.39M | Sell |
6,379
-220
| -3% | -$106K | 0.16% | 142 |
|
|
2023
Q3 | $3.34M | Sell |
6,599
-3,236
| -33% | -$1.72M | 0.15% | 132 |
|
|
2023
Q2 | $5.13M | Sell |
9,835
-4,907
| -33% | -$2.65M | 0.21% | 95 |
|
|
2023
Q1 | $1.93M | Sell |
14,742
-2,493
| -14% | -$1.41M | 0.08% | 240 |
|
|
2022
Q4 | $2.44M | Sell |
17,235
-1,596
| -8% | -$846K | 0.07% | 327 |
|
|
2022
Q3 | $2.93M | Buy |
18,831
+1,483
| +9% | +$830K | 0.08% | 285 |
|
|
2022
Q2 | $2.72M | Hold |
17,348
| – | – | 0.09% | 269 |
|
|
2022
Q1 | $2.72M | Buy |
17,348
+4,987
| +40% | +$2.86M | 0.09% | 269 |
|
|
2021
Q4 | $8.24M | Buy |
12,361
+1,134
| +10% | +$708K | 0.16% | 75 |
|
|
2021
Q3 | $6.41M | Buy |
11,227
+108
| +1% | +$59.3K | 0.13% | 90 |
|
|
2021
Q2 | $5.66M | Buy |
11,119
+439
| +4% | +$207K | 0.12% | 97 |
|
|
2021
Q1 | $4.87M | Sell |
10,680
-929
| -8% | -$443K | 0.09% | 100 |
|
|
2020
Q4 | $5.39M | Buy |
11,609
+11
| +0.1% | +$5.16K | 0.22% | 77 |
|
|
2020
Q3 | $5.12M | Buy |
11,598
+527
| +5% | +$218K | 0.31% | 64 |
|
|
2020
Q2 | $3.89M | Buy |
11,071
+1,548
| +16% | +$519K | 0.31% | 70 |
|
|
2020
Q1 | $2.7M | Buy |
9,523
+1,115
| +13% | +$352K | 0.27% | 81 |
|
|
2019
Q4 | $2.75M | Buy |
8,408
+2,523
| +43% | +$765K | 0.21% | 115 |
|
|
2019
Q3 | $1.68M | Buy |
+5,885
| New | +$1.69M | 0.11% | 208 |
|
|
2019
Q1 | $232K | Sell |
845
-11,017
| -93% | -$2.74M | 0.03% | 433 |
|
|
2018
Q4 | $2.64M | Sell |
11,862
-1,763
| -13% | -$414K | 0.16% | 147 |
|
|
2018
Q3 | $3.33M | Sell |
13,625
-325
| -2% | -$74.8K | 0.14% | 174 |
|
|
2018
Q2 | $2.89M | Buy |
13,950
+144
| +1% | +$30.6K | 0.12% | 188 |
|
|
2018
Q1 | $2.62M | Hold |
13,806
| – | – | 0.12% | 198 |
|
|
2017
Q4 | $2.62M | Sell |
13,806
-825
| -6% | -$158K | 0.12% | 199 |
|
|
2017
Q3 | $2.77M | Sell |
14,631
-771
| -5% | -$140K | 0.11% | 202 |
|
|
2017
Q2 | $2.69M | Buy |
15,402
+479
| +3% | +$80.5K | 0.11% | 204 |
|
|
2017
Q1 | $2.29M | Sell |
14,923
-804
| -5% | -$123K | 0.1% | 221 |
|
|
2016
Q4 | $2.22M | Buy |
15,727
+4,080
| +35% | +$602K | 0.11% | 209 |
|
|
2016
Q3 | $1.85M | Sell |
11,647
-66
| -0.6% | -$10.2K | 0.1% | 238 |
|
|
2016
Q2 | $1.73M | Buy |
11,713
+10,868
| +1,286% | +$1.6M | 0.1% | 240 |
|
|
2016
Q1 | $232K | Sell |
845
-7,311
| -90% | -$980K | 0.03% | 433 |
|
|
2015
Q4 | $1.16M | Buy |
+8,156
| New | +$1.09M | 0.08% | 274 |
|
Other funds holding TMO
IFP Advisors's TMO Position: Q2 2026 in Review
IFP Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, selling an estimated $36.5K and leaving 5,215 shares worth $2.61M. The position accounts for 0.05% of the portfolio, ranked #411.
IFP Advisors first reported a position in TMO in Q4 2015 and has held it in 42 quarters since. The position peaked at $8.24M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- IFP Advisors held 5,215 shares of Thermo Fisher Scientific worth $2.61M as of Q2 2026.
- IFP Advisors sold 76 Thermo Fisher Scientific shares in Q2 2026, an estimated $36.5K.
- Thermo Fisher Scientific made up 0.05% of IFP Advisors's portfolio in Q2 2026, its #411 holding.
- IFP Advisors first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 42 quarters since.
- IFP Advisors's Thermo Fisher Scientific position peaked at $8.24M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.